BRAIN Biotech AG (BNN) — Capital Reinvestment Ratio

Latest as of June 2024: 1.40x

BRAIN Biotech AG (BNN) has a Capital Reinvestment Ratio of 1.40x as of June 2024, meaning it reinvests 1% of its operating cash flow (€516.00K) in capital expenditures (€720.00K). See debt-free asset ratio of BRAIN Biotech AG to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

1.40x

Capex / Operating Cash Flow

Operating Cash Flow

€516.00K

EUR

Capital Expenditures

€720.00K

EUR

Data as of

Jun 2024

Most recent filing

Annual Capital Reinvestment Ratio for BRAIN Biotech AG (None–None)

Year-by-year Capital Reinvestment Ratio for BRAIN Biotech AG from None to None. For live market cap and broader valuation context, see how much is BRAIN Biotech AG worth.

Year	Reinvestment Ratio	Operating CF (EUR)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow